242 related articles for article (PubMed ID: 11713757)
1. Gene therapy using hematopoietic stem cells.
Kohn DB
Curr Opin Mol Ther; 1999 Aug; 1(4):437-42. PubMed ID: 11713757
[TBL] [Abstract][Full Text] [Related]
2. Progress towards hematopoietic stem cell gene therapy.
Kurre P; Kiem HP
Curr Opin Mol Ther; 2000 Aug; 2(4):400-11. PubMed ID: 11249770
[TBL] [Abstract][Full Text] [Related]
3. Progress toward the genetic treatment of the beta-thalassemias.
Sadelain M; Lisowski L; Samakoglu S; Rivella S; May C; Riviere I
Ann N Y Acad Sci; 2005; 1054():78-91. PubMed ID: 16339654
[TBL] [Abstract][Full Text] [Related]
4. A roadmap to safe, efficient, and stable lentivirus-mediated gene therapy with hematopoietic cell transplantation.
Neschadim A; McCart JA; Keating A; Medin JA
Biol Blood Marrow Transplant; 2007 Dec; 13(12):1407-16. PubMed ID: 18022569
[TBL] [Abstract][Full Text] [Related]
5. [Development of gene therapy for hematopoietic stem cell using viral vectors].
Dong WJ; Zu ZX; Liu DP; Liang CC
Yi Chuan Xue Bao; 2003 Apr; 30(4):382-8. PubMed ID: 12812066
[TBL] [Abstract][Full Text] [Related]
6. Gene transfer into hematopoietic progenitor and stem cells: progress and problems.
Dunbar CE; Emmons RV
Stem Cells; 1994 Nov; 12(6):563-76. PubMed ID: 7881358
[TBL] [Abstract][Full Text] [Related]
7. Recombinant factor VIII expression in hematopoietic cells following lentiviral transduction.
Tiede A; Eder M; von Depka M; Battmer K; Luther S; Kiem HP; Ganser A; Scherr M
Gene Ther; 2003 Oct; 10(22):1917-25. PubMed ID: 14502221
[TBL] [Abstract][Full Text] [Related]
8. Serial transplantations in nonobese diabetic/severe combined immunodeficiency mice of transduced human CD34+ cord blood cells: efficient oncoretroviral gene transfer and ex vivo expansion under serum-free conditions.
Gammaitoni L; Lucchi S; Bruno S; Tesio M; Gunetti M; Pignochino Y; Migliardi G; Lazzari L; Aglietta M; Rebulla P; Piacibello W
Stem Cells; 2006 May; 24(5):1201-12. PubMed ID: 16410386
[TBL] [Abstract][Full Text] [Related]
9. Gene therapy for hematopoietic and immune disorders.
Kohn DB
Bone Marrow Transplant; 1996 Dec; 18 Suppl 3():S55-8. PubMed ID: 8971410
[TBL] [Abstract][Full Text] [Related]
10. Cellular gene therapy.
Lee JH; Klein HG
Hematol Oncol Clin North Am; 1995 Feb; 9(1):91-113. PubMed ID: 7737946
[TBL] [Abstract][Full Text] [Related]
11. Update on gene therapy for hereditary hematological disorders.
Herzog RW; Arruda VR
Expert Rev Cardiovasc Ther; 2003 Jul; 1(2):215-32. PubMed ID: 15030282
[TBL] [Abstract][Full Text] [Related]
12. Lentivirus-mediated gene transfer into hematopoietic repopulating cells in baboons.
Horn PA; Morris JC; Bukovsky AA; Andrews RG; Naldini L; Kurre P; Kiem HP
Gene Ther; 2002 Nov; 9(21):1464-71. PubMed ID: 12378409
[TBL] [Abstract][Full Text] [Related]
13. Sustained transgene expression by human cord blood derived CD34+ cells transduced with simian immunodeficiency virus agmTYO1-based vectors carrying the human coagulation factor VIII gene in NOD/SCID mice.
Kikuchi J; Mimuro J; Ogata K; Tabata T; Ueda Y; Ishiwata A; Kimura K; Takano K; Madoiwa S; Mizukami H; Hanazono Y; Kume A; Hasegawa M; Ozawa K; Sakata Y
J Gene Med; 2004 Oct; 6(10):1049-60. PubMed ID: 15386735
[TBL] [Abstract][Full Text] [Related]
14. Targeted gene modification for gene therapy of stem cells.
Boggs SS
Int J Cell Cloning; 1990 Mar; 8(2):80-96. PubMed ID: 1968938
[TBL] [Abstract][Full Text] [Related]
15. Silencing p21(Waf1/Cip1/Sdi1) expression increases gene transduction efficiency in primitive human hematopoietic cells.
Zhang J; Attar E; Cohen K; Crumpacker C; Scadden D
Gene Ther; 2005 Oct; 12(19):1444-52. PubMed ID: 15877047
[TBL] [Abstract][Full Text] [Related]
16. Comparison of HIV- and EIAV-based vectors on their efficiency in transducing murine and human hematopoietic repopulating cells.
Siapati EK; Bigger BW; Miskin J; Chipchase D; Parsley KL; Mitrophanous K; Themis M; Thrasher AJ; Bonnet D
Mol Ther; 2005 Sep; 12(3):537-46. PubMed ID: 16099415
[TBL] [Abstract][Full Text] [Related]
17. Towards hematopoietic stem cell-mediated protection against infection with human immunodeficiency virus.
Schambach A; Schiedlmeier B; Kühlcke K; Verstegen M; Margison GP; Li Z; Kamino K; Bohne J; Alexandrov A; Hermann FG; von Laer D; Baum C
Gene Ther; 2006 Jul; 13(13):1037-47. PubMed ID: 16541120
[TBL] [Abstract][Full Text] [Related]
18. Successful correction of the human Cooley's anemia beta-thalassemia major phenotype using a lentiviral vector flanked by the chicken hypersensitive site 4 chromatin insulator.
Malik P; Arumugam PI; Yee JK; Puthenveetil G
Ann N Y Acad Sci; 2005; 1054():238-49. PubMed ID: 16339671
[TBL] [Abstract][Full Text] [Related]
19. US panel advises resumption of gene trials.
Fox JL
Nat Biotechnol; 2002 Nov; 20(11):1068-9. PubMed ID: 12410240
[No Abstract] [Full Text] [Related]
20. The effects of lentiviral gene therapy with bone morphogenetic protein-2-producing bone marrow cells on spinal fusion in rats.
Miyazaki M; Sugiyama O; Tow B; Zou J; Morishita Y; Wei F; Napoli A; Sintuu C; Lieberman JR; Wang JC
J Spinal Disord Tech; 2008 Jul; 21(5):372-9. PubMed ID: 18600149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]